Comparing Two Ways to Manage Head and Neck Lymphedema
Comparing Two Ways to Manage Lymphedema in Head and Neck Cancer Survivors
Abramson Cancer Center at Penn Medicine
300 participants
Mar 11, 2022
INTERVENTIONAL
Conditions
Summary
This randomized clinical trial aims to compare clinic-based CDT and home-based (a hybrid model) CDT on changes in the severity of lymphedema, symptom burden, functional status, and healthcare utilization in HNC survivors with lymphedema.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will be provided therapist-administered, in person complete decongestive therapy (CDT) two times per week for two weeks (4 sessions), followed by real-time, virtual CDT consultations two times per week for three weeks (7 sessions) and one in person follow-up visit.
Participants will be provided therapist administered, in-person CDT two times per week for six weeks (12 sessions).
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05182229